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Abstract: Problem statement: The aim of this study is to investigate the pharmacological effects of 
the Methanolic-extract (AH2) of El-Hazha and its sub-fractions. Approach: These investigations were 
carried out on in vitro isolated uterus preparations from Non-Pregnant (NP) and Late-Pregnant rats 
(LP). In parallel displacement radio-ligand binding assay was performed for β-Adrenergic Receptors 
(β-ADR). Results: Showed that the herb and its different fractions produced dose-dependent relaxant 
effect (p<0.05, t-test, n = 6) on uterine contraction elicit by 25 mM KCl in both NP and LP uteri that 
affected significantly by fractionation, however, the effect of the most active fraction (AH2-11) was 
reversed by prior addition of propranolol (non-specific β-antagonist), but not affected by progesterone 
pre treatment of the LP rats. In addition, AH2 only in high concentration displaced isotopes from β-
ADR, this affinity changed markedly by fractionation. Conclusion: We validate the fractionation 
effect on its relaxant activity and found partial role for β-ADR on mediating this activity. Future study 
was recommended to isolate and investigate its active components to enhance this activity or to 
discover a new novel natural therapeutic agent(s). 
 
Key words: Haplophylium tuberculatum, radio-ligand binding assay, β-Adrenergic Receptors (β-
ADR), Non-Pregnant (NP), Late-Pregnant rats (LP), Sudanese plant, charles-river 
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 Despite extensive efforts, the incidence of preterm 
birth has not decreased recent several decades (Monga 
and Creasy, 1995; Hannah, 2000). Preterm labor is still a 
health challenge, because there are as yet no effective 
primary means of its prevention (Koucky et al., 2009). 
 Tocolytic agents are drugs designed to inhibit the 
contractions of myometrial smooth muscle cells. The 
aim of tocolysis is not only to stop uterine contractions 
and to prevent preterm delivery, but also to decrease the 
prenatal morbidity and mortality associated with 
preterm birth (Tsatsaris et al., 2004). The main drugs 
used as tocolytics are indomethacin and other 
prostaglandins inhibitors (Vermillion and Landen, 
2001), calcium channel blockers such as nifedipine 
(Pryde et al., 2001; Giles and Bisits, 2007), β- 
adrenergic agonists and oxytocin receptors antagonist, 
while the Medical prevention consists of antibiotic or 
progesterone administration (Tara and Thornton, 2004). 
 One of the most well-known mechanism of action 
through which a tocolytic agent acts was to relax the 
uterus, so generally any agent has ability to relax the 
uterus can be considered as a tocolytic agent (Clouse et al., 
2007) demonstrates that relaxation of rat myometrium is 
mediated by β2-adrenoceptors. also α1/β-adrenoceptor 
ratio determines not only the spontaneous motor activity 
of the rat uterus, but also the potency of the agents with 
tocolytic effect (Zupko et al., 1998). 
 However, the efficacy and safety of tocolytics are 
not adequate, new agents are therefore required 
including substances from natural sources. Many plants 
have been recently investigated world-wide in the 
search for tocolytic or uterus-relaxing agent such as 
Curcuma aeruginosa Roxb. Rhizome (Thaina, 2009), 
Scutellaria baicalensis root (Shih et al., 2009) and 
Ficus capensis Thunb (Owolab et al., 2009). 
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 El-Hazha (Haplophyllum tuberculatum) (Forssk.) 
A. Juss. (Rutaceae); is an herb indigenous to the 
northern part of Sudan, North Africa and other areas of 
the Middle East (Boulus, 1983). Named locally in 
Sudan as “a plant of all disease”, it is to be found in 
every Sudanese home as an emergency drug that used 
extensively by old Sudanese in the rural areas. The herb 
is utilized in Sudan as an antispasmodic, as an 
antiflatulant, to relieve toothache and to treat allergic 
rhinitis (Mohamed AH et al., 1996), malaria, 
gynaecological disorders, asthma, inspiration 
difficulties, renal disorders and others. 
 This plant is also well known among herbalists and 
widely used traditionally in other counties such as 
Saudi Arabia (Mohammed et al., 1991) and Oman 
(Mossa et al., 1987). 
 Its essential oils were investigated for antimicrobial 
activity by (Al-Burtamani et al., 2005) and were found 
to cause partial inhibition of the growth of Escherichia 
coli, Salmonella choleraesuis and Bacillus subtilis to 
the same extent as gentamycin sulfate.  
 Its cardiovascular effect were studied by 
(Mohamed AH et al., 1996), who reported that its 
aqueous extract significantly decreased the contractility 
and the heart rate, but did not affect the flow rate of the 
isolated perfused rabbit heart. This action was not 
blocked by atropine, but the muscarinic antagonist 
blocked the fall in blood pressure seen when the extract 
was administered to anaesthetized cats. The extract also 
stimulated rabbit aortic strip, rat vas deferens and rat 
anococcygeus muscles. These adrenergic effects were 
largely reduced by phentolamine. 
 Its hepatoprotective activity was investigated on 
the liver damage induced by paracetamol in mice by 
(Ali et al., 2001) and proved to be relatively ineffective 
protecting only 16% of the animals against the lethal 
effect of paracetamol (1 g kg−1) in comparable to that of 
the standard hepatoprotective agent silymarin. 
 When its cytotoxic activity was checked against 11 
tumor cell lines, where strong cytotoxic activity was 
observed (Varamini et al., 1992). 
 On the other hands and from phytochemical's point 
of view, some compounds of this Sudanese plant were 
isolated by (Khalid and Waterman, 1981). 
 Both its uses to relax the uterus and to treat 
asthma and inspiration difficulties catalyzed us to 
carry out this study to evaluate their effects in order to 
find a new therapeutic agent(s) to aid in solving of two 
major medical challenges (preterm labor inhibition 
and asthma control). 
 Literature survey revealed that the aqueous extract 
of this plant obviously possess contracting activity, 
while traditional uses suggested contradictory 
applications such as muscle relaxant and contracting 
effect in the same time. 
 This study was an attempt to proof and evaluate 
some of its traditional uses in gynaecological area as 
uterus-relaxing agent and to see the influence of 
fractionation on its activity. 
 
MATERIALS AND METHODS 
 
Plant material:  
Crude plant collection and identification: The aerial 
parts of Haplophylum tuberculatum (El-Hazha) were 
collected freshly during the 1rst week of November 
2008 from their natural habitats in the North part of 
Sudan (Abu-hamad, Nahr El-Neel State). The voucher 
specimens (No. M23/08) were identified by Dr. Wai’l 
E. Abdalla and Yahia S. Mohamed of Herbarium of 
Medicinal and Aromatic Plants Research Institute 
(MAPRI), Khartoum, Sudan, where the specimens were 
also deposited for future references. 
 
Extraction, fractionation and preparation of the 
plant material for pharmacological tests:  The air-
dried powdered aerial parts of Haplophylum 
tuberculatum (AH) (2 kg) were extracted with 
Methanol for 1h. The MeOH extract (AH2) was 
concentrated and completely dried under vacuum to 
yields 315 g of the crude extract which reconstituted in 
distilled water to get the desired concentration and 
tested pharmacologically (Ganguly et al., 2007), then 
fractionated and tested. The most active fraction in each 
step was selected based on comparing the in vitro 
pharmacological results, then fractionated and tested. 
The most active fractions are (AH2-11) 88.31 g, (AH2-
11-4) 4.31 g and (AH2-11-4-6) 161mg (Fig. 1).  
 
Pharmacological studies: 
Ethical considerations for housing and handling the 
animals: The animals were treated in accordance with 
the European Communities Council Directives 
(86/609/ECC) and the Hungarian Act for the Protection 
of Animals in Research (XXVIII.tv.32. §). All 
experiments involving animal subjects were carried out 
with the approval of the Hungarian Ethical Committee 
for Animal Research (registration number: IV/1758-
2/2008). Sprague-Dawley rats (Charles-River 
Laboratories, Hungary) were kept at 22 ± 3°C, the 
relative humidity was 30-70% and the light/dark cycle 
was 12/12 h. They were maintained on a standard 
rodent pellet diet (Charles-River Laboratories, 
Hungary) with tap water available ad libitum. The 
animals were sacrificed by CO2 inhalation. 
 
Mating of the animals: Mature female (180-200 g) and 
male (240-260 g) rats were mated in a special mating 
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cage. A metal door, which was movable by a small 
electric engine, separated the rooms for the male and 
female animals. A timer controlled the function of the 
engine. Since rats are usually active at night, the 
separating door was opened before dawn. Within 4-5 h 
after the possibility of mating, vaginal smears were 
taken from the female rats and a sperm search was 
performed under a microscope at a magnification of 
1200 times. If the search proved positive, or if smear 
taking was impossible because of an existing vaginal 
sperm plug, the female rats were separated and were 
regarded as first day- pregnant animals. 
 
Isolated organ bath studies: Uteri were removed from 
non-pregnant (180-200 g), 22-day-pregnant (270-350 g) 
rats. Muscle rings 5 mm long were sliced from the 
uterine horns and mounted in an organ bath (8 parallels) 
containing 10 ml de Jongh solution (in mM: 137 NaCl, 
3 KCl, 1 CaCl2, 1 MgCl2, 12 NaHCO3, 4 NaH2PO4, 6 
glucose, pH 7.4). The organ bath was maintained at 37 o 
C and carbogen (95% O2+5% CO2) was bubbled through 
it. After mounting, the rings were equilibrated for about 1 
h before experiments were undertaken; with a solution 
change every 15 min. The initial tension was set to about 
1.5 g, which was relaxed to about 0.5 g at the end of 
equilibration. The tension of the myometrial rings was 
measured and recorded with a gauge transducer and an 
S.P.E.L. Advanced ISOSYS Data Acquisition System 
(Experimetria Ltd., Hungary), respectively. Contractions 
were elicited with KCl (25 mM) and cumulative dose-
response curves were constructed in each experiment by 
addition of plant extract or its fraction(s) in different 
concentrations (range from 10−5-100 µg ml−1) alone or in 
the presence of propranolol (β-blocker) (10−6 mM). 
Recording was performed for 5 minutes. Dose-response 
curves were fitted from areas under curves (AUCs) 
using Prism 4.0 computer program. Emax and EC50 
values were calculated (Emax: the maximum relaxant 
effect of extract or its fractions, EC50: the concentration 
of extract or its fraction (s) alone which elicits half of 
the maximum relaxant effect of extract or its fraction 
(s) or one of its fraction (s).  
 
Progesterone treatment of pregnant rats: The 
progesterone treatment of the pregnant rats was started 
on day 15 of pregnancy. Progesterone was dissolved in 
corn oil and injected subcutaneously every day up to 
day 21 at a concentration of 0.5 mg 0.1−1 ml kg−1. On 
day 22, the uteri were collected and the organ bath 
studies were performed as described above. The 
experimental data on the non-treated and the 
progesterone-treated animals were analyzed 
statistically. 
 
Radio-ligand binding assay:  
Membrane preparation: The selected tissue of 
abundant receptors of interest was rat brain membrane. 
Animals were sacrificed by rapid cervical dislocation, 
both side of the skull were cut from back to forward. 
The intact brain was expose and removed carefully 
using forceps. The brain were freed from other tissues 
and homogenized in ice-cold homogenizing buffer (20 
mM NaHCO3) in a ratio of 1:5. The homogenate was 
centrifuged at 15500 rpm speed for 40 min, the re-
suspended pellets were centrifuged under the same 
conditions. Finally the pellet were re-suspended in 
binding buffer (50 mM tris + 0.5 mM EDTA with pH = 
7.5) and divided into small stock aliquots 2.6 mL each 
and frozen at -70°C which diluted and used in radio-
ligand binding displacement assays.  
 
Displacement assay: The affinities of the tested extract 
and its fractions for β-adrenergic receptors were 
measured on above membrane preparation using [3H] 
Dihydroalprenolol (DHA) (β-adrenergic antagonist) as 
radioligand (~1.5 nM).Radioligand were purchased 
from Amersham International plc (UK). Under standard 
assay conditions, the final incubation system volume 
was 300 µl consisted of diluted membrane preparation 
(protein content approximately 0.5-1 mg ml−1), radio-
ligand and incubation buffer or with the tested extract 
or its fractions (its concentration ranging from 10−7-104 
µg mL−1), following the incubation period, the 
membranes were collected on a Whatman GF/C filter, 
using a Brandel M24 Cell Harvester. Filters were 
collected in liquid scintillation vials and the 
radioactivity was measured with LKB Wallac liquid 
scintillation counter. The experiment were performed at 
25°C for 45 min, the nonspecific binding were 
determined using 10−5M Alprenolol. Displacement 
experiments were analyzed individually with the 
computer program Prism 4.0 to determine the inhibition 
constants (Ki) of the investigated agents.  
 
Statistical analysis: The statistics was done by using 
Prism 4.0 (GraphPad Software, USA) computer 
program. For the statistical evaluations, data were 
collected from at least 6 animals and analyzed by 
performing two-tailed unpaired t-test to compare the 
significance mean differences for various results. The 





Phytochemical extraction and fractionation: The 
Methanolic-maceration of the plant produced a yield's 
percentage of (5.5%), while the steps of fractionations 
were highlighted in a summary diagram (Fig.1) 
emphasizing on that mentioned as most active 
pharmacologically and used throughout the study. 





Fig. 1: Diagram illustrated the main steps of Bioactivity-guided fractionation of the Methanolic-extract of El-Hazha 
emphasized on the most active fractions resulted and used throughout the study. 
 
Table1: The basic effects of the Methanolic-extract on non-pregnant 
and late-pregnant rat uterus in vitro results, general pilot 
screening for the direct plant relaxant activity 
Gestation period Emax ± SEM % EC50 ± SEM (µg mL−1) 
Non-pregnant  25.7 ± 3.6 (2.2 ± 0.6) ×10−3 
Late-pregnant  39.9 ± 5.8 (0.4 ± 0.3) ×10−3 
P-value  0.094 0.027 * 
*: p<0.05; Emax: The maximal relaxing effect of the Methanolic-
extract against (KCl-induced contraction); EC50: The concentration 
of the Methanolic-extract producing 50% of their maximal relaxing 
effect of Methanolic-extract against (KCl-induced contraction) in 
the system 
 
In vitro pharmacological studies:  
Rat uterus results: 
Effect of the Methanolic-extract on rat uteri: 
Basically, the extract showed relaxant activity in NP 
and LP rat uterus without significant difference in 
Emax (p = 0.094), but with significant difference in 
EC50 (p = 0.027), Table 1. 
Effect of the different AH2 fractions after the 2 nd 
and 3rd fractionation on rat uteri: AH2 and its 
fractions showed different activity level on both uteri 
type (data not shown), while the most active fraction 
was selected for the next step. 
 
Effect of the most active fractions of AH2 on rat 
uteri: In non-pregnant (Fig. 2A and Table 2), the basic 
AH2 relaxant activity was increased significantly after 
fractionation while it decreased by further fractionation. 
 In late-pregnant unlike non-pregnant results, (Fig. 
2B and Table 2), the extract activity was not 
significantly affected by different fractionations steps. 
 After this step the fraction AH2-11 was 
considered as the most active one and selected for 
the advanced β- adrenergic study using propranolol 
as standard blocker (Fig. 3 and Table 3) and 
progesterone treatment (Fig. 4). 
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Table 2:  Relaxant effect of the Methanolic-extract AH2 and its most active fractions on non-pregnant and late-pregnant rat uterus in vitro results  
 Non-pregnant  Pregnant D 22 
 ---------------------------------------------------------------- ------------------------------------------------------ 
 Emax ± SEM EC50 ± SEM Emax ± SEM EC50 ± SEM 
Fraction (%)  (µg mL−1) (%) (µg mL−1) 
AH2 25.6 ± 2.6 (2.2 ± 0.6) ×10-3 31.7 ± 5.4 (0.4± 0.3) ×10-3 
AH2-11 81.0 ± 12.6 * 1.3 ± 0.6  33.4 ± 4.5 (4.5 ± 3.8) ×10-2 
AH2-11-4 58.2 ± 5.0 (7.8 ±5.9) ×10-3 27.9 ± 5.2 (4.4 ± 2.1) ×10-5 
AH2-11-4-6 38.8 ± 6.3 (6.8 ±3.2) ×10-3 34.9 ± 3.5 (1.7 ± 0.7) ×10-4 
*p<0.05, AH2 was used as control for its different fractions, Emax: the maximal relaxing effect of the Methanolic-extract AH2 or its sub fractions 
(AH2-11, AH2-11-4 and AH2-11-4-6) against KCl-induced contraction; EC50: the concentration of the Methanolic-extract AH2 or its sub 
fractions (AH2-11, AH2-11-4 and AH2-11-4-6) producing 50% of their maximal relaxing effect of Methanolic-extract against KCl-induced 
contraction in the system 
 
Table 3: Propranolol antagonistic effect on the relaxant effect of the most active fraction AH2-11 on isolated non-pregnant and late-pregnant rat 
uterus in vitro 
 Non-pregnant  Pregnant D 22 
 ------------------------------------------------------------- ----------------------------------------------------- 
 Emax ± SEM EC50 ± SEM Emax ± SEM EC50 ± SEM 
Most active Fraction AH2-11 (%) (µg mL−1) (%) (µg mL−1) 
Alone 81.0 ± 12.6 1.3 ± 0.6 49.5 ± 3.9 (3.9 ± 3.2) ×10−2 
With Propranolol [10-6 M] 124.1 ± 16.9 (34.6 ± 8.8) ×10−2 29.5 ± 3.4 ** (0.5 ± 0.4) ×10−3 
*: p<0.05, Emax: the maximal relaxing effect of the most active fraction AH2-11 against KCl-induced contraction; EC50: The concentration of the 








Fig. 2: Dose-response curves of the relaxing effect of 
the Methanolic-extract (AH2) (continuous-line) 
and its most active fractions (dotted-lines) on 
non-pregnant (a) and late-pregnant (b) rat 
uterus in vitro against KCl-induced control 
contractions. Values presented are means of 6-8 
observations, while vertical bars denote 





Fig. 3: Dose-response curves of the most active 
fraction AH2-11 alone (continuous-lines) and 
with propranolol 10−6 (dotted-line) on non--
pregnant (a) and late-pregnant (b) on isolated 
rat uterus in vitro against KCl-induced control 
contractions. Values presented are means of 6-8 
observations, while vertical bars denote 
Standard Errors of the Mean (SEM) 





Fig. 4: Dose-response curves of the most active 
fraction AH2-11, untreated (continuous-lines) 
and progesterone-treated (dotted-line) on 
isolated late-pregnant rat uterus (Day22) in 
vitro against KCl-induced control contractions. 
Values presented are means of 6-8 
observations, while vertical bars denote 




Fig. 5: The displacement curves of AH2 and its most 
active fractions on β-adrenergic receptors using 
Dihydroalprenolol [3H] DHA as a radioligand 
and isotopes on rat brain membrane 
preparation. Values presented are means of 6-8 
observations, while vertical bars denote 
Standard Errors of the Mean (SEM) 
 
Propranolol effect on the relaxant activity of the 
most active fraction on rat uteri: Propranolol in 
concentration of 10−6 M had no significant effect on 
neither the curve nor its parameters of the most active 
fraction AH2-11 on non-pregnant rat uterus (Fig. 3A 
and Table 3). 
 On late-pregnant rat uterus (Fig. 3B and Table 3), 
propranolol in concentration of 10−6M exerts significant 
effect on the Emax% of the curve (p = 0.0049) but with 
insignificant (p=0.184) effect on the EC50 of the most 
active fraction AH2-11 under investigation. 
Effect of AH2-11 on late-pregnant progesterone-
treated rat uterus results: The progesterone treatment 
for late-pregnant rat uterus did not alter significantly 
neither the Emax% nor the EC50 of the curve of the most 
active fraction AH2-11 (Fig. 4). 
 
Radio-ligand binding assay: The affinity of the 
Methanolic-extract and its most active sub fractions 
from different fractionation steps for β-adrenergic 
receptors were tested on rat brain membrane 
preparation, using Dihydroalprenolol [3H] DHA (2 nM) 
as an isotopes radioligand. All of the ligands displace 
the radioligand from the target receptor. 
 The AH2 showed the displacement of the isotopes 
only in very high concentration (104 µg mL−1) with un-
estimated Ki ,while its other sub fractions showed 
better displacement affinities and the Ki-values of AH2-
11-4 and AH2-11-4-6 were (1.2 ±1.0) ×10−2 , (1.1 ±1.1) 




 Plants still a rich drug source (Wahab et al., 2008), 
El-Hazha, is named locally in Sudan as “a plant of all 
disease”. Due to its extensive use traditionally this plant 
subjected to different studies in different directions, but 
the novelty of this study arises from many factors 
which can be summarized as; deep pharmacological 
study with detailed assay guided fractionation, while 
other studies either general or used only the crude 
extract without fractionation, It involve the use of a 
pharmacological methods like RLB-assay and It done on 
both non-pregnant and late-pregnant (D22) rat uterus. 
 Traditionally El-Hazha is used as an aqueous 
infusion. In our investigation we made a Methanolic-
extract (AH2) from the plant, because the polarity of 
the two solvents are quite similar, the extract contains 
probably the same components. Previously, the aqueous 
extract of the plant was investigated by (Mohamed AH 
et al., 1996) and gives potent contracting activity. The 
chloroformic fraction contains non-polar compounds 
and it was never used traditionally.  
 In general pilot screening, AH2 exerts relaxant 
effect in both uteri with insignificant difference in 
Emax%, but the EC50 was significantly differ, while the 
RLB assay revealed that the extract exerts binding 
affinity to β-ADR only in relatively very high 
concentration, these findings necessitates its 
fractionation to clarify this affinity. 
 Fractionation gives different sub-fractions with 
different efficacies on both isolated uteri, but we deal 
only with the most active ones. Fractions that produce 
relaxation ≤35% on NP and ≤25% on LP after first 
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fractionation and that produce relaxation activity ≤25% 
on NP and 20% on LP after the 2nd fractionation 
process which calculated as Emax ±SEM% were 
mentioned and considered as active. Moreover, the 
fraction that showed best pharmacological activity was 
selected for the next steps. 
 The fractionation effect on the biological extract 
activity was achieved by relating AH2 to its most active 
fractions. In NP uterus, the extract activity was 
increased significantly (p = 0.026) by fractionation then 
markedly decreases, but still at a level (2X) greater. 
  In LP uterus the activity did not affected 
significantly by fractionation, but the original extract 
relaxant activity still exist. In spite that on this stage 
of pregnancy the sensitivity of the uterus to β-
adrenergic activity was weaker than the non pregnant 
(Gaspar et al., 2005). 
 These findings were supported with and confirmed 
by radio-ligand binding assay experiments results. In 
which at the beginning fractionation improved AH2 
affinity to β-ADR, but after the 3rd fractionation 
process the affinity was deteriorated to a level similar to 
the AH2 before fractionation. 
 We continue the study using the most active sub 
fraction AH2-11, because we thought that this relaxant 
effect may be attributed to synergistic effects of the 
extract compounds that can be explain by the huge 
number of compounds that appears in the TLC plate 
(not shown here). 
 The selected Fraction AH2-11 as most active one 
when used to perform further experiments to verify the 
role of β-adrenergic receptor in mediating the above 
mentioned relaxant activity using propranolol as a 
blocker, both rat uteri revealed that; in NP, propranolol 
has no effect on the fraction's relaxant activity which 
may be taken as an evidence of a role of other 
mechanism(s) involves rather than β-ADR such as 
direct muscle effect (Ali et al., 1992) or Ca+-channel 
blocking activity. But in the LP data the β-ADR was 
clearly identified by the propranolol antagonistic effect 
on the fraction activity in which its dose -response 
curve was significantly (p = 0.0049) shifted to the right.  
 Further conformity test for the β-ADR role in this 
relaxation was done by pre-treatment of pregnant rats 
by progesterone because (Gálik et al., 2008) reported 
that, Progesterone pre-treatment increases the 
expression of the β2-ADR during pregnancy and alters 
the effects of β2-ADR agonists on the pregnant 
myometrium. In addition, gestagen-induction increases 
in the myometrial β2-ADR density and the amount of 
activated G proteins coupled to β-ADRs.  
 Although (Gaspar et al., 2005) found on the late 
stage of pregnancy the sensitivity of the uterus to β-
adrenergic activity was weaker than the non-pregnant, 
unfortunately the progesterone treatment did not 
potentiate the β-receptors sensitivity to this fraction, 
these findings can be explained by that, the β-ADR only 
partially participated in this relaxation besides other 
possible mechanism(s) or may be hide by the presence of 
other compounds in this semi-purified fraction.  
 TLC chromatogram showed the complexity of the 
active fractions. Even the sub-sub-sub fraction contains 
large number of structurally related compounds exists 
in a very small amount, thus their isolation is a very 
difficult process. These compounds may contribute the 
various traditional uses and the local name (plant of all 
diseases) of the plant. Finally, the separation may affect 
markedly its biological activity due to the well-known 




 Finally we can concluded that, by these findings 
and demonstration we confirm and proof its mentioned 
traditional use, even it seems contradictory from the 
first point of view, The fractionation significantly affect 
the activity of its Methanolic-extract. 
 There is a partial role for β-ADR on mediating this 
relaxation activity or may be its complete, but inhibited 
by the existence of other contracting substances that 
needs further separation and isolation.  
 The suggested purification may lead to a discovery 
of a new novel natural therapeutic agent(s) useful to aid 
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